OncoCyte: Melinda Griffith

OncoCyte has appointed Melinda Griffith to its board of directors. Griffith is a senior executive who has led business development, licensing, and legal activities for a number of diagnostic, device and pharmaceutical companies. In addition to her board appointment for OncoCyte, she currently serves as vice president of strategic alliances and chief legal counsel for the Parker Institute for Cancer Immunotherapy an dis chair of the board of directors for intenrational health non-profit Thrive Networks.

Prior to this, Griffith held a number of executive roles at public and private biotech companies, including GE Healthcare's Clarient Cancer Laboratories, Genelabs Technologies, CardioDx, Tethys BioSciences, and Axys Pharmaceuticals, Cetus Corporation, and Hoffmann La-Roche.